Postsurgical Analgesia After Hernia Repair

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 27, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

May 31, 2026

Conditions
HerniaHernia, Abdominal
Interventions
DRUG

AMT-143 hydrogel containing containing ropivacaine

AMT-143 is provided as a hydrogel containing 385 mg/mL ropivacaine (on a ropivacaine HCl equivalence basis). AMT-143 hydrogel will be provided as pre-filled syringes for administration via instillation into the surgical site after surgery and prior to suture.

DRUG

Ropivacaine

5 mL Ropivacaine 10 mg/mL (1%) solution

OTHER

Placebo

Saline Placebo

Trial Locations (1)

L8S 4K1

McMaster University, Hamilton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AmacaThera Inc.

INDUSTRY

NCT06709612 - Postsurgical Analgesia After Hernia Repair | Biotech Hunter | Biotech Hunter